Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis
Clinical trial NCT00794664 · COMPLETED
Trial details
- NCT number
- NCT00794664
- Sponsor
- Kastle Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-05-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.